T-group (topology)
66.1.1 ISP domain
Ligands and drugs
1,320
Member domains
348
with ligand contacts (≤ 4 Å)
26.4% of members
328
with DrugDomain annotations
24.8% of members
121
with a DrugBank compound
9.2% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 66.1.1 belongs to X-group 66 ISP domain, which binds 7.4 ligand superclasses per 20 proteins, narrower than 54% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB04327 | PEE | Phosphatidylethanolamine | 21 |
| DB03317 | HEC | Ferroheme C | 8 |
| DB01728 | PEF | 1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine | 3 |
| DB09270 | U10 | Ubidecarenone | 3 |
| DB01117 | AOQ | Atovaquone | 2 |
| DB02777 | PLC | Diundecyl Phosphatidyl Choline | 2 |
| DB02806 | MXE | 2-Methoxyethanol | 2 |
| DB03350 | NCO | Cobalt hexammine ion | 2 |
| DB03429 | CDL | Tetrastearoyl cardiolipin | 2 |
| DB00145 | GLY | Glycine | 1 |
| DB00172 | PRO | Proline | 1 |
| DB02686 | UMQ | Undecyl-Beta-D-Maltopyranoside | 1 |
| DB04141 | — | 2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol | 1 |
| DB04799 | — | 6-Hydroxy-5-undecyl-4,7-benzothiazoledione | 1 |
| DB07401 | — | Azoxystrobin | 1 |
| DB07636 | — | 5-Heptyl-6-hydroxy-1,3-benzothiazole-4,7-dione | 1 |
| DB07640 | DCQ | 2-decyl-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione | 1 |
| DB07763 | — | (5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE | 1 |
| DB07778 | — | (S)-famoxadone | 1 |
| DB08330 | — | METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| FES | FE2/S2 (INORGANIC) CLUSTER | 205 |
| CL | CHLORIDE ION | 23 |
| SMA | STIGMATELLIN A | 12 |
| HEC | HEME C | 9 |
| UNL | Unknown ligand | 7 |
| 3H1 | 3-chloro-4,6-dihydroxy-2-methyl-5-{(2E,4E)-3-methyl-5-[(1R,2R,6R)-1,2,6-trimethyl-3-oxocyclohexyl]penta-2,4-dien-1-yl}benzaldehyde | 2 |
| CAmetal | CALCIUM ION | 2 |
| I7Y | (2R)-2-(methoxymethyl)-4-{[(25R)-spirost-5-en-3beta-yl]oxy}butyl 4-O-alpha-D-glucopyranosyl-beta-D-glucopyranoside | 2 |
| ICX | methyl N-[(5Z)-6-({[4-(4-iodobenzyl)phenyl]carbonyl}amino)hex-5-enoyl]glycinate | 2 |
| JHB | 7-chloranyl-3-methyl-2-[4-[[4-(trifluoromethyloxy)phenyl]methyl]phenyl]-1~{H}-quinolin-4-one | 2 |
| MGmetal | MAGNESIUM ION | 2 |
| MXE | 2-METHOXYETHANOL | 2 |
| NAmetal | SODIUM ION | 2 |
| PG0 | 2-(2-METHOXYETHOXY)ETHANOL | 2 |
| PRmetal | PRASEODYMIUM ION | 2 |
| U10 | UBIQUINONE-10 | 2 |
| GLY | GLYCINE | 1 |
| NCO | COBALT HEXAMMINE(III) | 1 |
| NImetal | NICKEL (II) ION | 1 |
| NM2 | 3-CARBOXY-N,N,N-TRIMETHYLPROPAN-1-AMINIUM | 1 |